Nov 30, 2025 09:05
JNJ - Johnson & Johnson
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 203.79 1.1 (0.54%) | -0.23 (-0.11%) | -0.44 (-0.21%) | -0.86 (-0.42%) | 0.41 (0.2%) | 0.93 (0.46%) | 0.5 (0.25%) | 0.74 (0.36%) |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- 2.3
- Diluted EPS:
- 2.29
- Basic P/E:
- 89.0826
- Diluted P/E:
- 89.4716
- RSI(14) 1m:
- 34.08
- VWAP:
- 205.02
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 30, 2025 04:12
Nov 29, 2025 10:17
Nov 27, 2025 16:00
Nov 27, 2025 14:00
Nov 27, 2025 11:30
Nov 27, 2025 09:01
Nov 26, 2025 15:22
Nov 25, 2025 17:22
Nov 24, 2025 15:29